LABT Appoints Study Chair
Lakewood-Amedex Biotherapeutics appoints Dr. David G. Armstrong as study chair for Phase 2a trial of Nu-3 in infected diabetic foot ulcers
LABT LABT - Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G.
Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers